×
0 0 0 0 0 0 0 0
Stockreport

Here's Why AnaptysBio, Inc. Stock Surged on Wednesday [The Motley Fool]

ANAPTYSBIO (ANAB)  More Company Research Source: The Motley Fool
Last anaptysbio earnings: 8/10 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com
PDF Investors eager for more news about the company's anti-allergy candidate have a date to look forward to. Cory Renauer ( TMFang4apples ) Feb 7, 2018 at 4:44PM What happened Shares of AnaptysBio, Inc. ( NASDAQ:ANAB ) , a clinical-stage biotechnology company, rose 11.1% in midday trading on Wednesday before locking in a 9.4% gain to end the day. Investors appear excited about a recently announced engagement at the annual meeting of the American Academy of Dermatology. So what  On Saturday, Feb. 17, AnaptysBio will present data from a phase 2a atopic dermatitis (eczema) trial involving the most advanced candidate the company owns outright, ANB020. The novel new drug candidate inhibits interleukin-33 (IL-33), a mediator of skin-related disorders. Image source: Getty Images. Since IL-33 acts upstream of IL-4 and IL-13, two proteins inhibited b [Read more]

IMPACT SNAPSHOT EVENT TIME: ANAB
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ANAB alerts
from News Quantified